DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Overview Fund Activity
Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

173 hedge funds and large institutions have $1.25B invested in Dicerna Pharmaceuticals, Inc. in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 64 increasing their positions, 58 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
173
Holders Change
-29
Holders Change %
-14.36%
% of All Funds
3.04%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
28
Increased
64
Reduced
58
Closed
56
Calls
$15.1M
Puts
$4.49M
Net Calls
+$10.6M
Net Calls Change
+$8.12M

Top Buyers

1
State Street
State Street
Massachusetts
$78.3M
2
CC
Commodore Capital
New York
$26.1M
3
EC
EcoR1 Capital
California
$25.2M
4
GPP
Great Point Partners
Connecticut
$16.1M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
$27.2M

Top Sellers

1
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
$0
2
Wellington Management Group
Wellington Management Group
Massachusetts
$10.8M
3
PA
Perceptive Advisors
New York
$0
4
EA
Emerald Advisers
Pennsylvania
$0
5
NAMA
Nikko Asset Management Americas
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Point72 Asset Management
26
Point72 Asset Management
Connecticut
$12.8M -$1.71M -85,000 -12%
DCM
27
DAFNA Capital Management
California
$11.8M +$1.55M +76,700 +15%
Two Sigma Investments
28
Two Sigma Investments
New York
$11.6M +$5.93M +294,355 +105%
Wellington Management Group
29
Wellington Management Group
Massachusetts
$10.8M -$55.8M -2,765,749 -84%
Charles Schwab
30
Charles Schwab
California
$10.4M +$350K +17,340 +3%
Fidelity Investments
31
Fidelity Investments
Massachusetts
$10.4M -$2.12M -105,100 -17%
MWNA
32
Marshall Wace North America
New York
$10.3M +$10.3M +511,674 New
Invesco
33
Invesco
Georgia
$8.68M +$4.84M +240,293 +126%
Nuveen Asset Management
34
Nuveen Asset Management
Illinois
$8.32M -$1.07M -53,014 -11%
EHI
35
Eagle Health Investments
Connecticut
$8.2M +$4.95M +245,400 +152%
CS
36
Candriam SCA
Luxembourg
$7.93M -$501K -24,855 -6%
Millennium Management
37
Millennium Management
New York
$7.28M +$519K +25,736 +8%
UBS AM
38
UBS AM
Illinois
$6.66M -$206K -10,203 -3%
Voloridge Investment Management
39
Voloridge Investment Management
Florida
$6.63M +$5.38M +266,797 +429%
Norges Bank
40
Norges Bank
Norway
$6.12M +$6.12M +303,591 New
Bank of New York Mellon
41
Bank of New York Mellon
New York
$5.7M -$532K -26,396 -9%
Balyasny Asset Management
42
Balyasny Asset Management
Illinois
$5.6M +$3.86M +191,393 +221%
Citadel Advisors
43
Citadel Advisors
Florida
$5.27M -$1.46M -72,328 -22%
Federated Hermes
44
Federated Hermes
Pennsylvania
$4.58M -$3.37M -167,114 -42%
EMFAT
45
Emerald Mutual Fund Advisers Trust
Pennsylvania
$4.5M -$4.81M -238,633 -52%
Axa
46
Axa
France
$4.26M -$1.33M -66,020 -24%
PHP
47
Parkman Healthcare Partners
Connecticut
$4.23M -$1.92M -95,000 -31%
Russell Investments Group
48
Russell Investments Group
United Kingdom
$4.17M +$566K +28,079 +16%
Mirae Asset Global Investments
49
Mirae Asset Global Investments
South Korea
$4.12M +$790K +39,179 +24%
SSA
50
Schonfeld Strategic Advisors
New York
$4.11M +$3.2M +158,795 +354%
1
2
3 4 5